Conférences  >  Médecine & Soins de Santé  >  Cancérologie

The European Association for Cancer Research (EACR)

This meeting will provide participants with a broad view of the scope, methodologies, future directions and challenges in addition to practical approaches for molecular pathology, focusing on comprehensive genomic profiling in cancer, in research and in clinical settings. We will discuss innovative approaches for empowering the next generation of molecular pathologists from practical and educational viewpoints. Upcoming applications of multiparametric immunoanalysis, liquid biopsy and artificial intelligence in pathology will be addressed. The meeting will help participants to establish a network of interactions and to build bridges to foster cross disciplinary studies. We are preparing for the future and for the unknown discoveries still to come.

European Molecular Biology Organization – EMBO

The unique glycolytic behaviour is present in nearly all cancer cell types. Cancer cells quickly adapt and reprogram glucose metabolism to meet their bioenergetic and biosynthetic requirements for growth and survival. A key to developing novel and effective cancer therapies is to tackle the complex metabolic ecosystem that cancer and stroma cells establish within the tumour microenvironment. This metabolic ecosystem ensures the high demand of energy and essential nutrients for tumour progression. Research on the distinct metabolic phenotype of cancer cells compared to normal cells is growing steadily to target metabolic vulnerabilities for new therapeutics in cancer. This India I EMBO Lecture Course will bring together eminent researchers and experts across the disciplines of cancer and molecular biology, structural biology, bioinformatics, medicinal chemistry and drug discovery, to share the recent advances, challenges, and opportunities in the field of tumour metabolism and drug discovery.

Biologie,    Biologie moléculaire

Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie

Das Vorprogramm mit einem vorläufigen Programmraster wird im Herbst 2022 veröffentlicht. Für die Frühjahrstagung werden DFP-Punkte für das Diplom-Fortbildungsprogramm der Österreichischen Ärztekammer beantragt.

OeGHO Akademie für Aus- und Fortbildung GmbH | Onconovum.academy;     Tél.: [+43 1 934 62 67];     Email.: academy@onconovum.at

Médecine (en général), médecine interne,    Hématologie

IDEOlogy Health

IDEOlogy Health has developed this educational meeting that will engage physicians and allied health professionals on the latest advances for the treatment of lung cancer. The goal of this activity is to provide a comprehensive update to medical oncologists and healthcare providers (academic and community) on the evolving treatments in thoracic oncology.

oncology, thoracic oncology, lung cancer, cancer, surgical oncology, immunotherapy, cme

Binaytara Foundation

The “BTF Multidisciplinary Breast Cancer Conference” is a CME-accredited activity featuring experts in breast cancer. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in field. Expert faculty will aim to place the role of different therapeutic agents in clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Tél.: [4255575953];     Email.: meggan.m@binayfoundation.org

breast cancer, cancer, oncology, cme, medical, healthcare, conference,

The European Association for the Study of the Liver (EASL)

Baptist Health South Florida, CME

The Miami Cancer Institute Women’s Cancer Symposium brings together a distinguished faculty for a one-day live symposium that will focus on the medical management of common and important challenges facing healthcare professionals who care for women with cancer. The multispecialty approach allows participants to explore new diagnoses and cutting-edge treatment options for various areas of breast and ovarian cancer patient care in a concise symposium format.

Email.: kamilap@baptisthealth.net

Formation médicale continue (FMC),    Gynécologie/obstétrique

Thomas Jefferson University

The inaugural Wills Eye and Thomas Jefferson University Hospitals Orbital Tumor Symposium features critical deliberations regarding patient cases, clinical findings, differential diagnoses, and management plan options. Participants will examine cases from multiple perspectives and gain an in-depth understanding of how experienced health care providers approach difficult patient care decisions.

Keynote lectures from leading practitioners provide evidence for care decision discussed in panels which will increase confidence in diagnostic and treatment decision making for participants. This innovative course will be of interest to clinicians treating periorbital tumors and malignancy which includes ophthalmologists, otolaryngologists, radiation oncologists, medical oncologists, dermatologists, radiologists, and trainees.

Office of CPD;     Tél.: [2159556992];     Email.: jeffersoncpd@jefferson.edu

Dermatology, Reconstructive Surgery, Orbital

Formation médicale continue (FMC),    Dermatologie

European Association for Cancer Research (EACR)

This virtual conference will share recent advancements in tissue stem cells biology and the link to cancer heterogenicity and plasticity. Using a variety of experimental model systems, the conference offers a holistic view of the molecular programs of cellular plasticity (both cell-intrinsic and microenvironmental) which drive healthy stem cell functions as well as cancer growth. Increased knowledge on the abnormal stemness behaviour holds the potential for novel therapeutic interventions against cancer. Key topics include the fundamentals of tissue stem cells biology, stem cell niches and aging, and the drivers of cellular plasticity in cancer.

Tél.: [N/A];     Email.: kathryn.wass@eacr.org

tissue stem cells, cancer plasticity, cancer heterogenicity, cancer research, cancer therapies, experimental model systems, cellular plasticity, molecular programs, cell-intrinsic plasticity, microenvironmental cellular plasticity, abnormal stemness behaviour, stem cell niches, stem cell aging, oncology.

Attend the 3rd & the 4th International Research Society of Sapporo Conference for Palliative and Supportive Care in Cancer in Japan. The aim of the conference is to focus on fundamental and clinical research, based on palliative oncology and psycho-oncology and seeks to contribute to cancer care. Symposium 1 will center around the theme “Opioid and cancer pain”.

Binaytara Foundation

This annual oncology conference, 2023 Summit on Cancer Health Disparities: Reframing and addressing barriers to adoption of precision oncology, will feature lectures, panel discussions and debates among leaders across the spectrum of cancer care delivery. This conference will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss the factors leading to cancer health disparities and ways to overcome the impact of these factors to optimize outcomes of cancer patients.

Tél.: [4255575953];     Email.: meggan.m@binayfoundation.org

Oncologist and Hematologists, Oncology and Hematology Nurse Practitioners, Oncology and Hematology Physician Assistants, Oncology and Hematology Nurses, Oncology and Hematology Pharmacists, Oncology and Hematology Fellows/Residents, Oncology and Hematology Researchers, Others interested in cancer disparities

Fusion Conferences

This meeting will involve leaders in the field who study the biological basis of breast cancer, develop approaches for patient stratification, run clinical trials or develop new medicines for patients with breast cancer.

The European Association for Cancer Research (EACR)

Following the highly successful first, second and third editions, Defence is the Best Attack 2023 will be the fourth EACR conference on this topic. In this conference, we will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Binaytara Foundation

The Alaska Multidisciplinary Oncology Conference is a 1-day educational and scientific meeting that will focus on key clinical topics in the management of common malignancies. This conference will feature leading experts discussing the latest diagnostic, therapeutic, and supportive care strategies in cancer management. The field of oncology is continually evolving with the introduction of new targeted therapies, cellular therapies, and immunotherapy. These advances present new opportunities to tailor treatment approaches for cancer patients based on disease-related and patient-related factors. Significant disparities exist in access to continuing education for physicians practicing in rural settings. Engaging, easily accessible continuing education activities focusing on content that has practical applications for the provider may significantly impact patient outcomes. There is a need for these educational activities in rural settings to update practicing healthcare providers about recent advances in the field. This highly practical and interactive symposium will provide a unique opportunity for healthcare professionals to learn from and interact with well-known experts in the field.

Tél.: [4255575953];     Email.: meggan.m@binayfoundation.org

Oncology, Medical, Cancer, Conference

The meeting in Mainz will focus on “advanced endocrine malignancies”. Especially in advanced oncologic cases, we are faced with many uncertainties; the opinions about indications for and limits of surgery are very diverse. As usual, ESES working groups will prepare profound statements based on in-depth literature reviews and research data for malignancies of thyroid, adrenals, and the gastroenteropancreatic neuroendocrine system. Of course, original research results will also be presented at the meeting.

Email.: info@wikonect.de

Binaytara Foundation

This CME-accredited activity “Multiple Myeloma & Lymphoma Summit” features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to, CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Event and Communication Assistant;     Tél.: [4255575953];     Email.: tiani.g@binayfoundation.org

conference, CME, continuing education, oncology, utah, cancer research, healthcare equity

Hématologie,    Formation médicale continue (FMC)

Thomas Jefferson University

The ultimate goal of this conference is improve the care of patients with pancreatic and related cancers by focusing on improvements to the diagnostic methods, treatment strategies, and supportive care. Through didactic lectures, case based presentations, and lively discussion with expert faculty, participants will review of the latest technologies and procedures and will be able to improve their delivery of care, determine the need for referrals sooner, and achieve better patient outcomes.

Office of CPD;     Tél.: [215-955-6992];     Email.: jeffersoncpd@jefferson.edu

Pancreas Cancer, Surgery, Gastroenterology

Deutsche Gesellschaft für Radioonkologie e. V.

Auf dem Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO) haben alle Fachkollegen/innen der DEGRO Gelegenheit, alle für die Entwicklung der Radioonkologie wichtigen Aspekte in konzentrierter Form zu diskutieren und: so zu einem breiten Erkenntnisaustausch zu kommen. Herausragende Forschungsleistungen werden auf diesem Kongress durch Wissenschaftspreise ausgezeichnet. An diesem Kongress sind auch die Angehörigen der in der Radioonkologie tätigen weiteren Berufsgruppen der MTRA (VMTRO), der Pflegenden in der Radioonkologie (BVPRO), der Medizinischen Fachangestellten in der Radioonkologie (MFAaBRO) und der Officeberufe (OVIRO) aktiv beteiligt.

Die Programmschwerpunkte des DEGRO-Kongress 2023 sind: Neue Technologien – neue Dosiskonzepte | High Tech – High Care: Der Patient im Mittelpunkt | Digitalisierung und Artificial Intelligence | Radio-Immuntherapie, Radio-Chemotherapie or what? | Arbeit im multiprofessionellen Team.

Kongressorganisation;     Tél.: [+49 3643 2468-0];     Email.: degro@kukm.de

Radioonkologie, Onkologie, Radiotherapie, Medizinphysik, Strahlenbiologie, Radioimmuntherapie, Radiochemotherapie, Digitalisierung, AI, Patientenzentrierung

Radiologie, médecine nucléaire et radiothérapie,    Médecine translationnelle, essais cliniques

Binaytara Foundation

This CME-accredited oncology conference, Best of ASCO 2023, Portland, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.

This oncology conference features some of the most well-known experts in the field of hematology and oncology who will provide a comprehensive overview of noteworthy data presented at the 2023 ASCO® Annual Meeting (ASCO2023) in June of 2023. The program includes in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field and a scientific abstract session. Expert faculty will place abstract findings from ASCO2023 into clinical context and discuss how the results may change the current standard of care.

Event Planner;     Tél.: [4255575953];     Email.: shahtara@binayfoundation.org

ASCO, BTF

European Molecular Biology Organization – EMBO

Biologie,    Biologie des systèmes

The European Association for Cancer Research

This highly interactive, workshop-style online conference will cover a broad range of topics, particularly focusing on the personal experiences of our invited speakers and their practical advice on the career-related questions early-career researchers have told us they have. Topics include mental health, gender in research, successful paper-writing, and tips for securing funding, network building, and finding your career path. This is the third edition of this conference and there will be plenty of chances to turn on your camera and mic to speak directly with the experts.

The target audience for this conference is scientists in the early phase of their career who want to develop a career in cancer research. The programme is tailored for scientists in the process of starting their independent path, as well as for researchers engaging with the clinical and industrial applications of their work.

Speakers: Arianna Baggiolini (Institute of Oncology Research, Switzerland), Maria Caffarel (Biodonostia, Spain), Arkaltz Carracedo (CIC bioGUNE, Spain), Sankari Nagarajan (University of Manchester, UK), Elisa Oricchio (EPFL, Switzerland)

Registration deadline: 29 May 2023

Email.: kathryn.wass@eacr.org

early career research, basic cancer research career, translational cancer research career, clinical cancer research, industrial cancer research cancer research, career advice, oncology

Médecine translationnelle, essais cliniques,    Pharmacogénétique, Médecine personnalisée

While animal modeling has been a staple of the cancer biology community for decades, it is only now maturing to its fullest potential. This conference will provide a forum for discussion on the past, present, and future of animal models for cancer, in particular the role that these models will play in the era of precision medicine.

Binaytara Foundation

CME-accredited oncology conference being held in person in Seattle, WA. This conference features lectures and discussions with leading experts in cellular therapies. The goal of this oncology conference is to improve the knowledge, competence, and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients receiving cellular therapies for hematologic and non-hematologic disorders. The conference agenda includes an in-depth discussion and analysis of the latest scientific findings and practice-changing advances in chimeric antigen receptor (CAR) based therapies. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Event Planner;     Tél.: [4255575953];     Email.: support@binayfoundation.org

CLL/NHL, ALL, MULTIPLE MYELOMA, SOLID TUMORS, SUPPORTIVE CARE

Formation médicale continue (FMC),    Hématologie

Oxford Global Conferences

Connecting global academic & research organisations as well as pharma representatives for high-level discussions on the latest innovations in spatial research & technologies.

Oxford Global Conferences;     Tél.: [+44 1865 248455];     Email.: d.dalby@oxfordglobal.co.uk

Spatial Biology, Oncology, Cardiovascular Diseases, Drug Discovery & Development, Personalised Medicine, Biomarkers, Spatial Data Analysis, Toxicology

Biologie,    Pharmacologie et développement des médicaments

Conventus Congressmanagement & Marketing GmbH

Email.: conferencemarketing@conventus.de

Oxford Global Conferences

Join oligo leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the oligonucleotides chemistry & therapeutics development.

Tél.: [+44 1865 248455];     Email.: h.liddiard@oxfordglobal.co.uk

Oligonucleotides chemistry, biotechnology, oncology, Genetic disorders, Rare diseases, Infectious diseases, Cardiovascular diseases, Kidney diseases

Biologie moléculaire,    Biotechnologie

Binaytara Foundation

This CME-accredited activity 2023 Annual Summit on Hematologic Cancers features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myeloproliferative neoplasms, multiple myeloma, and lymphoma.

Event Planner;     Tél.: [4255575953];     Email.: support@binayfoundation.org

Oncology, cancer, CME, hematology malengenices, acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myeloproliferative neoplasms, multiple myeloma, lymphoma, btf

Binaytara Foundation

The 2023 Midwest Precision Oncology Symposium, is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. Designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.

Event Planner;     Tél.: [4255575953];     Email.: support@binayfoundation.org

precision-oncology, oncology, molecular-targeted-treatment, molecular-targeted-therapies, CME, ACCME

Deutsche Gesellschaft für Neuroradiologie e.V.

Kongressmotto Kommunikation und Vernetzung für eine starke Neuroradiologie

Die Deutsche Gesellschaft für Neuroradiologie (DGNR) und die Österreichische Gesellschaft für Neuroradiologie (ÖGNR) laden zur gemeinsamen Jahrestagung nach Kassel ein.

Deutsche Gesellschaft für Neuroradiologie e.V.;     Email.: dgnr@neuroradiologie.de

Neuroradiologie, Radiologie, Onkologie, Neuroonkologie, MRT und CT

Bio Ascend LLC

The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts—from laboratory-based research to the clinic—in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for 4 days every other year.

Chronic lymphocytic Leukemia, ( CLL)

Formation médicale continue (FMC),    Hématologie

Binaytara Foundation

The 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.

Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2023 ASCO Annual Meeting in June 2023.

Event Planner;     Tél.: [4255575953];     Email.: support@binayfoundation.org

oncology, CME-credits

European Molecular Biology Laboratory | EMBL

Liquid biopsies have the advantage of being largely non-invasive and providing a vast amount of information for the detection and monitoring of diseases such as cancer. This course will provide an overview in the several techniques to detect and analyse circulating tumour cells (CTCs), cell free tumor DNA (ctDNA), miRNA in liquid biopsies, cell free tumour RNA (ctRNA) and proteins. Participants will be introduced to all aspects ranging from proper sampling through error free sequencing to data analysis. Additional lectures will cover extracellular vesicles and clinical aspects using liquid biopsies, especially in the field of cancer diagnostics. 

Biologie,    Foire exposition chimie,

The European Association for Cancer Research (EACR)

The EACR Goodbye Flat Biology conference returns in-person to focus on the next generation of cancer models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, intravital imaging and high-content analysis for cancer therapeutics.

Conventus Congressmanagement & Marketing GmbH

Conventus Congressmanagement & GmbH;     Email.: conferencemarketing@conventus.de